ReviewNature plants2026
The unfulfilled potential of nanocarriers for RNA delivery in antiviral crop protection.
Review in Nature plants, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Advancing the adoption of RNA interference-based biopesticides.Nature plants · 2026Review
- Nano-enabled spray-induced RNA interference against fungal pathogens of oilseed crops: carrier performance, delivery evidence and field translation.World journal of microbiology & biotechnology · 2026Review
- BioCNT-TLS engineered systemic mobile resistome for sustainable crop protection.Frontiers in plant science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Gene silencing mediated by double-stranded RNA (dsRNA) is a promising strategy for crop protection. However, unlike applications targeting fungi or insects, effective antiviral use of exogenous dsRNA requires delivery into the plant cytoplasm, where viruses replicate. Limited cellular uptake and rapid instability on leaf surfaces have driven the development of diverse nanocarrier platforms, including layered double hydroxides, carbon nanotubes, mesoporous silica nanoparticles, chitosan complexes, lipid-based particles and bacterially encapsulated dsRNA. Although these systems often enhance dsRNA stability and apoplastic accumulation, robust symplastic delivery remains poorly characterized. Here we critically examine the gap between experimental success and agronomic performance of nanocarrier-enabled dsRNA delivery systems. Comparative analyses suggest that carrier dose, size, ζ-potential and organic phase affinity influence systemic translocation within the plant, providing a framework for rational carrier design. Defining such principles will be essential for translating RNA-based antiviral strategies into reliable field applications.
Indexed as
Identifiers
42277378What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.